0QNO
Lonza Group AG
Stock London Stock Exchange – Stock Market Prices, News & Analysis
Swiss life sciences group specializing in the production of active pharmaceutical ingredients, biotechnology, and specialty chemicals.
Lonza Group AG
0QNO
Swiss life sciences group specializing in the production of active pharmaceutical ingredients, biotechnology, and specialty chemicals.
Price history of Lonza Group AG
Price history of Lonza Group AG
Performance & Momentum
Strategic Analysis
Lonza Group AG • 2026
Lonza Group AG is a leading Swiss player in the life sciences sector, focused on the production of active pharmaceutical ingredients, biotechnology, and specialty chemicals. Its strength lies in its integrated model and its position as a key contract manufacturing partner for the global pharmaceutical industry.
- Recognized expertise in pharmaceutical and biotechnology contract manufacturing
- Diversified portfolio combining specialty chemicals and clinical research
- Strategic positioning in Europe with a reputation for Swiss quality
- Negative stock performance over several years, reflecting sector challenges
- Exposure to long and complex cycles of pharmaceutical projects
The overall weak momentum reflects a period of underperformance amid sector and macroeconomic pressures. This calls for increased caution for retail investors, awaiting an operational or sector recovery before considering a repositioning.
Similar stocks to Lonza Group AG
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
